We are live on ! Find out more
MRNA icon

Moderna
MRNA

106 hedge funds and large institutions have $2.8B invested in Moderna in 2019 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 18

40% more capital invested

Capital invested by funds: $2.01B → $2.8B (+$795M)

34% more funds holding

Funds holding: 79 → 106 (+27)

17% more call options, than puts

Call options by funds: $6.91M | Put options by funds: $5.9M

1.44% more ownership

Funds ownership: 40.61% → 42.05% (+1.4%)

9% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 23

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

Holders
106
Holders Change
+27
Holders Change %
+34.18%
% of All Funds
2.29%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
45
Increased
25
Reduced
23
Closed
18
Calls
$6.91M
Puts
$5.9M
Net Calls
+$1.01M
Net Calls Change
+$995K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$23.4M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$15.8M
3
AAMU
Amundi Asset Management US
Massachusetts
+$13.7M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$10.1M
5
BlackRock
BlackRock
New York
+$10.1M

Top Sellers

Rank Fund Capital Flow
1
HCM
Highline Capital Management
New York
-$10.9M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$7.67M
3
SC
Samlyn Capital
New York
-$4.96M
4
AG
Artal Group
Luxembourg
-$4.64M
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$4.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCA
101
Catalyst Capital Advisors
New York
$6K – – –
SWM
102
SeaCrest Wealth Management
New York
$4K -$1.86K -100 -33%
MIM
103
MetLife Investment Management
New Jersey
$733 +$668 +36 New
GT
104
Glenmede Trust
Pennsylvania
$61 +$55.7K +3,000 New
SC
105
Samlyn Capital
New York
– -$4.96M -325,000 Closed
ACH
106
ArrowMark Colorado Holdings
Colorado
– -$3.2M -209,759 Closed
MAM
107
Myriad Asset Management
Hong Kong
– -$2.92M -190,943 Closed
WMSA
108
Weiss Multi-Strategy Advisers
New York
– -$878K -57,500 Closed
MF
109
Magnetar Financial
Illinois
– -$764K -50,000 Closed
Point72 Asset Management
110
Point72 Asset Management
Connecticut
– -$764K -50,000 Closed
PHK
111
Point72 Hong Kong
Hong Kong
– -$509K -33,319 Closed
Susquehanna International Group
112
Susquehanna International Group
Pennsylvania
– -$473K -25,494 Closed
SGH
113
Sivik Global Healthcare
Connecticut
– -$382K -25,000 Closed
BFM
114
Boothbay Fund Management
New York
– -$229K -15,000 Closed
Jane Street
115
Jane Street
New York
– -$189K -12,390 Closed
ACM
116
Atika Capital Management
New York
– -$153K -10,000 Closed
KSCM
117
Kamunting Street Capital Management
Florida
– -$137K -9,000 Closed
FIA
118
FNY Investment Advisers
New York
– -$22K -1,500 Closed
HI
119
Hudock Inc
Pennsylvania
– -$14K -1,000 Closed
FANJ
120
Financial Architects (New Jersey)
New Jersey
– -$8K -500 Closed
CG
121
Cutler Group
California
– -$1K -100 Closed
Group One Trading
122
Group One Trading
Illinois
– -$427 -23 Closed
WAM
123
Wealthspire Advisors (Maryland)
Maryland
– +$167 +9 New
1 2 3 4
5

MRNA Hedge Fund Activity: Q1 2019 in Review

106 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q1 2019, worth a combined $2.8B — up 40% from $2.01B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new MRNA positions and 18 closed out — a net gain of 27 holders — while 25 added to existing stakes and 23 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $23.4M. The largest seller was Highline Capital Management, cutting an estimated $10.9M.

  • 106 institutional investors held Moderna (MRNA) as of Q1 2019, up from 79 in Q4 2018.
  • Funds reported $2.8B of Moderna stock for Q1 2019, up 40% quarter-over-quarter.
  • 45 funds opened new Moderna positions in Q1 2019 and 18 closed out, a net change of +27 holders.
  • The largest Moderna buyer in Q1 2019 was Morgan Stanley, an estimated $23.4M added.
  • The largest Moderna seller in Q1 2019 was Highline Capital Management, an estimated $10.9M sold.

Based on aggregated 13F filings for Q1 2019.